​News​

On May 27, 2026, an initiative on microbe-attachment prevention technology by a joint development team consisting of Gel Coat Biomaterials, Inc. Institute of Microbial Chemistry (IMC), and The University of Tokyo was featured in the Nikkan Kogyo Shimbun. The article introduces a newly developed coating technology that highly effectively prevents the attachment of "biofilms," which are aggregates of microorganisms. This technology applies "hydrogel"—a polymer containing a larg

Gel Coat Biomaterials, Inc. (Chiyoda-ku, Tokyo; CEO: Shin Yoshida, hereafter “GCB”) announced that it has successfully raised JPY 200 million through a Series A financing round via a third-party allotment of shares. The investors include The WUV 1st Fund (official name: WUV 1 Limited Partnership)managed by WASEDA University Ventures, and Soken Chemical & Engineering Co., Ltd..GCB also plans an additional JPY 100 million extension round. Biomolecules such as enzymes and antibo

Gel Coat Biomaterials, Inc. (Tokyo, Japan) announces that CE O Shin Yoshida will deliver a lecture at the 106th Annual Meeting of the Chemical Society of Japan, which will be held from March 17 to March 20, 2026. In this lecture, Yoshida will introduce the company’s proprietary biomaterial technology “Gel Coat™ ”, a zwitterionic hydrogel platform designed to stabilize biomolecules such as enzymes, nucleic acids, and membrane proteins. Biomolecules are widely recognized as pro